PNC FINANCIAL SERVICES GROUP, INC. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$0297
+18.8%
0.00%
Q2 2020$0
-100.0%
250
-68.8%
0.00%
Q4 2019$3,000
-40.0%
801
-46.6%
0.00%
Q2 2019$5,000
-37.5%
1,500
-29.5%
0.00%
Q1 2019$8,000
+33.3%
2,1280.0%0.00%
Q4 2018$6,0000.0%2,1280.0%0.00%
Q3 2018$6,000
+20.0%
2,128
+6.4%
0.00%
Q2 2018$5,000
-16.7%
2,0000.0%0.00%
Q1 2018$6,000
-14.3%
2,000
-20.0%
0.00%
Q4 2017$7,000
-41.7%
2,500
-28.6%
0.00%
Q3 2017$12,000
+20.0%
3,500
-22.2%
0.00%
Q2 2017$10,0000.0%4,5000.0%0.00%
Q1 2017$10,000
+11.1%
4,5000.0%0.00%
Q4 2016$9,000
-40.0%
4,500
-4.3%
0.00%
Q3 2016$15,000
-48.3%
4,700
-52.0%
0.00%
Q2 2016$29,000
-12.1%
9,791
-1.6%
0.00%
Q1 2016$33,000
+13.8%
9,953
+22.7%
0.00%
Q4 2015$29,000
-57.4%
8,114
-39.4%
0.00%
Q3 2015$68,000
-87.1%
13,393
-83.6%
0.00%
-100.0%
Q2 2015$527,000
-9.3%
81,909
-0.8%
0.00%0.0%
Q1 2015$581,000
+13.9%
82,567
+24.8%
0.00%0.0%
Q4 2014$510,000
-14.0%
66,142
-16.5%
0.00%0.0%
Q3 2014$593,000
+77.5%
79,206
+129.6%
0.00%
Q2 2014$334,000
+312.3%
34,493
+254.9%
0.00%
Q1 2014$81,000
+97.6%
9,720
+100.4%
0.00%
Q4 2013$41,000
-19.6%
4,850
-24.7%
0.00%
Q3 2013$51,000
+21.4%
6,444
+15.2%
0.00%
Q2 2013$42,0005,5940.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders